Published in J Neurooncol on June 03, 2010
Cancer diagnostics: The journey from histomorphology to molecular profiling. Oncotarget (2016) 0.75
Does adjuvant external-beam radiotherapy improve outcomes for nonbenign meningiomas? A Surveillance, Epidemiology, and End Results (SEER)-based analysis. J Neurosurg (2012) 2.29
Phase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases. J Neurosurg (2014) 2.03
Microglia in diseases of the central nervous system. Ann Med (2002) 1.66
Intra-arterial delivery of bevacizumab after blood-brain barrier disruption for the treatment of recurrent glioblastoma: progression-free survival and overall survival. World Neurosurg (2011) 1.62
Quality of life and behavioral follow-up study of pediatric survivors of craniopharyngioma. J Neurosurg (2005) 1.58
Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses. J Immunol (2009) 1.53
High-viscosity polymethylmethacrylate cement for endoscopic anterior cranial base reconstruction. J Neurosurg (2010) 1.50
Multifocal stroke from tumor emboli. Arch Neurol (2009) 1.48
Recombinant mouse hepatitis virus strain A59 from cloned, full-length cDNA replicates to high titers in vitro and is fully pathogenic in vivo. J Virol (2005) 1.36
Multinodular and vacuolating neuronal tumors of the cerebrum: 10 cases of a distinctive seizure-associated lesion. Brain Pathol (2013) 1.13
Involvement of skeletal muscle in dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy). Muscle Nerve (2004) 1.12
Activated EGFR signaling increases proliferation, survival, and migration and blocks neuronal differentiation in post-natal neural stem cells. J Neurooncol (2009) 1.11
Superselective intraarterial cerebral infusion of bevacizumab: a revival of interventional neuro-oncology for malignant glioma. J Exp Ther Oncol (2009) 1.10
Neural stem cell biology may be well suited for improving brain tumor therapies. Cancer J (2003) 1.05
Gamma Knife surgery for the treatment of melanoma metastases: the effect of intratumoral hemorrhage on survival. J Neurosurg (2008) 1.04
Glioblastoma stem cells are regulated by interleukin-8 signaling in a tumoral perivascular niche. Cancer Res (2013) 1.03
Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmine. J Neuroimmunol (2008) 1.03
Zero-profile Anchored Spacer Reduces Rate of Dysphagia Compared With ACDF With Anterior Plating. J Spinal Disord Tech (2015) 1.01
Novel VLDLR microdeletion identified in two Turkish siblings with pachygyria and pontocerebellar atrophy. Neurogenetics (2010) 0.99
Results and risk factors for recurrence following single-level tubular lumbar microdiscectomy. J Neurosurg Spine (2010) 0.99
Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas. Neurosurg Focus (2011) 0.96
New strategy for the analysis of phenotypic marker antigens in brain tumor-derived neurospheres in mice and humans. Neurosurg Focus (2008) 0.95
Prostate-specific membrane antigen as a potential novel vascular target for treatment of glioblastoma multiforme. Arch Pathol Lab Med (2011) 0.95
Superselective intra-arterial cerebral infusion of novel agents after blood-brain disruption for the treatment of recurrent glioblastoma multiforme: a technical case series. Neurosurg Clin N Am (2012) 0.94
Amino acid substitutions within the heptad repeat domain 1 of murine coronavirus spike protein restrict viral antigen spread in the central nervous system. Virology (2003) 0.93
Endovascular embolization of cervical hemangiopericytoma with Onyx-18: case report and review of the literature. J Neurointerv Surg (2010) 0.92
Coronavirus neurovirulence correlates with the ability of the virus to induce proinflammatory cytokine signals from astrocytes and microglia. J Virol (2004) 0.92
Long-term expansion of adult human brain subventricular zone precursors. Neurosurgery (2008) 0.92
Glioblastoma stem-like cells-biology and therapeutic implications. Cancers (Basel) (2011) 0.91
The duality of epidermal growth factor receptor (EGFR) signaling and neural stem cell phenotype: cell enhancer or cell transformer? Curr Stem Cell Res Ther (2006) 0.91
Understanding the role of tumor stem cells in glioblastoma multiforme: a review article. J Neurooncol (2010) 0.89
Large congenital melanotic nevi in an extremity with neurocutaneous melanocytosis. Pediatr Dermatol (2009) 0.88
Differential induction of apoptosis in demyelinating and nondemyelinating infection by mouse hepatitis virus. J Neurovirol (2002) 0.87
Effects of high-fat diet and regular aerobic exercise on global gene expression in skeletal muscle of C57BL/6 mice. Metabolism (2011) 0.86
Optimization of glioblastoma multiforme stem cell isolation, transfection, and transduction. J Neurooncol (2011) 0.86
Protein phosphatase 2A mediates dormancy of glioblastoma multiforme-derived tumor stem-like cells during hypoxia. PLoS One (2012) 0.86
alpha-Defensin: link between inflammation and atherosclerosis. Atherosclerosis (2006) 0.85
Phase I/II study of oral erlotinib for treatment of relapsed/refractory glioblastoma multiforme and anaplastic astrocytoma. J Exp Ther Oncol (2012) 0.85
February 2002: 29-year-old woman with a skull mass for 2 months. Brain Pathol (2002) 0.85
EGFR signaling is differentially activated in patient-derived glioblastoma stem cells. J Exp Ther Oncol (2010) 0.85
The contribution of Notch signaling to glioblastoma via activation of cancer stem cell self-renewal: the role of the endothelial network. Neurosurgery (2012) 0.84
Effect of DAB(389)IL-2 immunotoxin on the course of experimental autoimmune encephalomyelitis in Lewis rats. J Neurol Sci (2007) 0.83
Four novel SCN1A mutations in Turkish patients with severe myoclonic epilepsy of infancy (SMEI). J Child Neurol (2010) 0.82
A combination of mutations in the S1 part of the spike glycoprotein gene of coronavirus MHV-A59 abolishes demyelination. J Neurovirol (2004) 0.81
Use of human neural tissue for the generation of progenitors. Neurosurgery (2008) 0.81
Tight regulation between cell survival and programmed cell death in GBM stem-like cells by EGFR/GSK3b/PP2A signaling. J Neurooncol (2014) 0.80
Assessing neural stem cell motility using an agarose gel-based microfluidic device. J Vis Exp (2008) 0.80
Direct conversion of human fibroblasts to functional neurons in one step. Neurosurgery (2011) 0.79
Orthotopic glioblastoma stem-like cell xenograft model in mice to evaluate intra-arterial delivery of bevacizumab: from bedside to bench. J Clin Neurosci (2012) 0.79
Neural stem cells and glioma stem-like cells respond differently to chemotherapeutic drugs: selectivity at the cellular level. Neurosurgery (2011) 0.79
The role of dose escalation with intracavitary brachytherapy in the treatment of localized CNS malignancies: outcomes and toxicities of a prospective study. Brachytherapy (2009) 0.79
Stereotactic radiosurgery plays a critical role in enhancing long-term survival in a patient with pancreatic cancer metastatic to the brain. Anticancer Res (2013) 0.78
Parasellar xanthogranulomas. J Neurosurg (2015) 0.78
Pituitary carcinoma diagnosed on fine needle aspiration: Report of a case and review of pathogenesis. Cytojournal (2010) 0.78
Notch inhibition via micro-RNA blocks glioma development. Neurosurgery (2012) 0.77
Therapeutic stem cells encapsulated in a synthetic extracellular matrix selectively kill tumor cells, delay tumor growth, and increase survival in a mouse resection model of malignant glioma. Neurosurgery (2012) 0.77
Industry progress report on neuro-oncology: Biotech update 2013. J Neurooncol (2013) 0.77
Multiple epidural lumbar chordomas without bone involvement in a 17-year-old female: a case report. Spine J (2011) 0.77
Disease-specific induced pluripotent stem cells. Neurosurgery (2008) 0.77
Toxicity evaluation of prolonged convection-enhanced delivery of small-molecule kinase inhibitors in naïve rat brainstem. Childs Nerv Syst (2014) 0.76
Dissecting the perivascular stem-cell niche: can we take tumor recurrence down a NOTCH? Neurosurgery (2012) 0.76
Prophylactic plastic surgery closure of neurosurgical scalp incisions reduces the incidence of wound complications in previously-operated patients treated with bevacizumab (Avastin®) and radiation. J Neurooncol (2014) 0.76
Feasibility and safety of GliaSite brachytherapy in treatment of CNS tumors following neurosurgical resection. J Cancer Res Ther (2010) 0.76
Targeting a heterogeneous tumor: the promise of the interleukin-13 receptor α2. Neurosurgery (2014) 0.75
High frequency of IDH-1 mutation links glioneuronal tumors with neuropil-like islands to diffuse astrocytomas. Acta Neuropathol (2011) 0.75
VIGAS and beyond: the impact of HCMV-infection and its treatment in glioblastoma. Neurosurgery (2014) 0.75
Magnetic Resonance Imaging to Identify Glioblastoma Molecular Phenotypes. Neurosurgery (2016) 0.75
Toxin-secreting implantable therapeutic stem cells. Neurosurgery (2015) 0.75
Industry progress report on neuro-oncology: a biotech update. J Neurooncol (2013) 0.75
Transdifferentiation Induced Neural Stem Cells for the Treatment of Malignant Gliomas. Neurosurgery (2016) 0.75
CD1a Reactivity in Non-neoplastic Adenohypophysis. Am J Surg Pathol (2016) 0.75
EGFR targeted inhibition resistance: compensatory activation of ERBB family members in glioblastoma cancer stem-like cells promotes proliferation. Neurosurgery (2012) 0.75
Stem cell based growth factory delivery to the injured spinal cord. Neurosurgery (2010) 0.75
Forcing tumor stem cells to an end. Neurosurgery (2010) 0.75
The FIRST Trial: Implications for Neurosurgery. Neurosurgery (2016) 0.75
Stem cell migration in a novel model to study pediatric brain tumors. Neurosurgery (2008) 0.75
Repurposing mebendazole for the treatment of medulloblastoma. Neurosurgery (2015) 0.75
Intra-arterial bevacizumab with blood brain barrier disruption in a glioblastoma xenograft model. J Exp Ther Oncol (2012) 0.75
Brain tumor stem cells: will understanding a new paradigm lead to improved therapies? Expert Rev Neurother (2008) 0.75
Stem cell populated implanted trachea. Neurosurgery (2009) 0.75
A New Tool in Defining Disease Progression in Glioblastoma. Neurosurgery (2015) 0.75
Getting a neural stem cell from a fibroblast. Neurosurgery (2012) 0.75
Trials and tribulations of cancer immunotherapy: the dendritic cell vaccine shows promise in a phase I glioblastoma multiforme trial. Neurosurgery (2012) 0.75
Radiation Exposure and Safety Precautions Following 131Cs Brachytherapy in Patients with Brain Tumors. Health Phys (2017) 0.75
Gross Total Resection of Glioblastoma Improves Overall Survival and Progression-Free Survival Compared to Subtotal Resection or Biopsy Alone. Neurosurgery (2016) 0.75
Interstitial infusion of erlotinib in the rodent brain. J Exp Ther Oncol (2009) 0.75
Cost analysis of intra-arterial versus intra-venous delivery of bevacizumab for the treatment of recurrent glioblastoma multiforme. J Exp Ther Oncol (2011) 0.75
Coronavirus-induced demyelination occurs in the absence of CD28 costimulatory signals. J Neuroimmunol (2004) 0.75
Resetting the stem cell clock: impact of the systemic milieu on oligodendrocyte precursor cell differentiation and remyelination. Neurosurgery (2012) 0.75
Neural stem cells: targeting glioma in 3-dimensions. Neurosurgery (2010) 0.75
Solitary fibrous tumor with multiple intracranial and spinal lesions: case report. Neurosurgery (2011) 0.75
Novel hydrogel application in minimally invasive surgical approaches to spontaneous intracranial hypotension. Report of 2 cases. J Neurosurg (2014) 0.75
Transdifferentiation-Induced Neural Stem Cells for the Treatment of Malignant Gliomas. Neurosurgery (2016) 0.75